**Patient Discharge Summary**

**Patient Details:**  
Name: [Patient Name]  
DOB: [Date of Birth]  
MRN: [Medical Record Number]  
Date of Admission: October 10, 2023  
Date of Discharge: October 17, 2023  
Admitting Physician: Dr. [Admitting Physician Name]  
Primary Diagnosis: Influenza  

**Hospital Course:**  
[Patient Name], a [age]-year-old patient with a past medical history significant for [significant past medical history, if any], was admitted to the infectious diseases unit on October 10, 2023, with symptoms indicative of influenza, including high fever, severe muscle aches, cough, and fatigue. Given the prevalence of influenza in the community and the patient's presenting symptoms, a clinical diagnosis of influenza was considered.

Upon admission, a nasopharyngeal swab was collected, and RT-PCR testing for influenza was performed, confirming the diagnosis of Influenza Type A. The patient's oxygen saturation was monitored using pulse oximetry, revealing mild hypoxemia, which necessitated supplemental oxygen via nasal cannula. A chest x-ray was performed to evaluate for pneumonia, which displayed signs of interstitial infiltrates, consistent with primary influenza pneumonia.

**Treatment:**  
Given the patient's confirmed diagnosis and within 24 hours of symptom onset, antiviral therapy was initiated. [Patient Name] was started on Oseltamivir 75 mg orally twice a day for a duration of 5 days, beginning on October 10, 2023. Symptomatic treatment for fever and muscle aches included acetaminophen 650 mg orally every 6 hours as needed. Due to the patient's mild hypoxemia, supplemental oxygen was provided, which was gradually tapered off as the patient's oxygen saturation levels improved.

Throughout the hospital stay, the patient was monitored for signs of secondary bacterial infection, dehydration, and other complications. Fortunately, the patient demonstrated significant improvement in symptoms, with resolution of fever by October 13, 2023, and improvement in respiratory symptoms by October 15, 2023. By October 17, 2023, the patient was deemed stable for discharge, with substantial resolution of initial presenting symptoms.

**Discharge Instructions:**  
1. **Medications:** Complete the Oseltamivir course as prescribed. Continue to use acetaminophen as needed for fever or discomfort, not exceeding 4 grams per day.
2. **Activity:** Rest is recommended for the next several days, with gradual return to normal activities as tolerated.
3. **Follow-up:** A follow-up appointment with the primary care physician is scheduled for October 24, 2023, to ensure complete recovery. If symptoms reappear or worsen, seek medical attention immediately.
4. **Prevention:** Practice good hand hygiene and avoid close contact with sick individuals to prevent the spread of influenza. Discuss the annual influenza vaccine with your primary care physician as a preventative measure for future influenza seasons.

**Warnings:**  
- Monitor for any signs of secondary bacterial infection, including persistent fever, worsening cough, or difficulty breathing, and seek immediate medical care if these symptoms occur.
- Avoid the use of aspirin or aspirin-containing products to reduce the risk of Reye's syndrome.

**Conclusion:**  
[Patient Name] was successfully treated for Influenza Type A with a course of Oseltamivir and supportive care. The patient showed significant improvement and was discharged in a stable condition with instructions for rest, medication adherence, and follow-up care.

**Physician's Signature:**  
Dr. [Admitting Physician Name]  
Date: October 17, 2023